159 related articles for article (PubMed ID: 6534868)
1. Serum ceruloplasmin levels in patients of leukaemias, Hodgkin's and non-Hodgkin's lymphomas.
Aggarwal AK; Sanwalka AB; Vadehra PL; Prabhakar BR
Indian J Pathol Microbiol; 1984 Oct; 27(4):347-52. PubMed ID: 6534868
[No Abstract] [Full Text] [Related]
2. Serum ceruloplasmin levels in Hodgkin's disease and malignant lymphomas in correlation with serum copper levels.
Sirsat AV; Raste AS; Talavdekar RV; Advani SH
Indian J Cancer; 1979 Jun; 16(2):32-4. PubMed ID: 546729
[No Abstract] [Full Text] [Related]
3. Serum copper, serum ceruloplasmin, and erythrocyte sedimentation rate measurements in children with Hodgkin's disease, non-Hodgkin's lymphoma, and nonmalignant lymphadenopathy.
Margerison AC; Mann JR
Cancer; 1985 Apr; 55(7):1501-6. PubMed ID: 3978543
[TBL] [Abstract][Full Text] [Related]
4. Distribution of ABO blood groups in acute leukaemias and lymphomas.
Vadivelu MK; Damodaran S; Solomon J; Rajaseharan A
Ann Hematol; 2004 Sep; 83(9):584-7. PubMed ID: 15175895
[TBL] [Abstract][Full Text] [Related]
5. [Quantitative measurement and clinical analysis of serum levels of immunosuppressive acidic protein (IAP) in hematopoietic malignancies].
Hamaguchi H; Karitani Y; Minami N; Tanaka I; Iwata Y; Shirakawa S
Gan To Kagaku Ryoho; 1984 Jun; 11(6):1231-6. PubMed ID: 6732251
[TBL] [Abstract][Full Text] [Related]
6. [Blood ceruloplasmin levels in acute lymphoblastic leukemia and Hodgkin's disease in childhood].
Masi M; Vecchi V; Vivarelli F; Paolucci P
Minerva Pediatr; 1975 Jun; 27(22):1223-8. PubMed ID: 1056499
[No Abstract] [Full Text] [Related]
7. Discriminant analysis of Hodgkin's disease and non-Hodgkin's lymphomas by age and serum proteins.
Merucci P; Taggi F; Marolla A; Abbolito MR; Vitelli G; Marolla P; Meliffi L; Chiarotti F; Ippolito FM; Ameglio F
Eur J Cancer Clin Oncol; 1984 Oct; 20(10):1243-7. PubMed ID: 6567527
[TBL] [Abstract][Full Text] [Related]
8. Ceruloplasmin in Hodgkin's disease.
Koprivová H; Dienstbier Z; Sámal M; Foltýnová V
Neoplasma; 1982; 29(3):333-40. PubMed ID: 7133228
[TBL] [Abstract][Full Text] [Related]
9. Serum interleukin 6 levels are elevated in lymphoma patients and correlate with survival in advanced Hodgkin's disease and with B symptoms.
Kurzrock R; Redman J; Cabanillas F; Jones D; Rothberg J; Talpaz M
Cancer Res; 1993 May; 53(9):2118-22. PubMed ID: 8481913
[TBL] [Abstract][Full Text] [Related]
10. Epstein-barr virus-associated non-Hodgkin's lymphoma of B-cell origin, Hodgkin's disease, acute leukemia, and systemic lupus erythematosus: a serologic and molecular analysis.
Mitarnun W; Pradutkanchana J; Takao S; Saechan V; Suwiwat S; Ishida T
J Med Assoc Thai; 2002 May; 85(5):552-9. PubMed ID: 12188384
[TBL] [Abstract][Full Text] [Related]
11. Serum ferritin levels in hematologic malignant neoplasms.
Patel AR; Shah PC; Vohra RM; Hart WL; Shah JR
Arch Pathol Lab Med; 1980 Oct; 104(10):509-12. PubMed ID: 6932189
[TBL] [Abstract][Full Text] [Related]
12. Erythrocyte survival in leukemia, Hodgkin's disease and malignant lymphoma as determined by radiochromate.
WAGGENER RE; PRATT PT; HUNT HB
Am J Roentgenol Radium Ther Nucl Med; 1958 Jun; 79(6):1045-9. PubMed ID: 13533682
[No Abstract] [Full Text] [Related]
13. Dendritic reticulum cell immunoreactivity for low-affinity nerve growth factor receptor in malignant lymphomas.
Dorfman DM; Shahsafaei A
Mod Pathol; 1996 Oct; 9(10):959-65. PubMed ID: 8902831
[TBL] [Abstract][Full Text] [Related]
14. Lymphocytic characterization in Hodgkin's and non-Hodgkin's lymphoma.
Kamthan M; Joshi N; Sharma ML
Indian J Pathol Microbiol; 1982 Apr; 25(2):139-43. PubMed ID: 6982850
[No Abstract] [Full Text] [Related]
15. [Acute non-lymphoblastic leukemias during Hodgkin's and non-Hodgkin's lymphomas in remission: a distinct cytogenetic entity].
Gyger M; Forest L
Union Med Can; 1980 Aug; 109(8):1212-5. PubMed ID: 7210330
[No Abstract] [Full Text] [Related]
16. Alterations of plasma levels in malignant lymphoma.
Opat P; Rejthar A; Tomanová J; Trnka A; Wotke R
Neoplasma; 1981; 28(3):339-43. PubMed ID: 7290261
[TBL] [Abstract][Full Text] [Related]
17. CA 125 elevations in patients with malignant lymphomas.
Fehm T; Beck E; Valerius T; Gramatzki M; Jäger W
Tumour Biol; 1998; 19(4):283-9. PubMed ID: 9679739
[TBL] [Abstract][Full Text] [Related]
18. Collagenolytic activity in leukocytes isolated from patients with leukemias and Hodgkin's disease.
Kucharz E; Drózdz M
Neoplasma; 1978; 25(5):621-4. PubMed ID: 216937
[TBL] [Abstract][Full Text] [Related]
19. Serum levels of ceruloplasmin, properdin factor B and copper in lymphoma patients.
Casamassima A; Addabbo L; Caporusso L; Lorusso V
Int J Biol Markers; 1991; 6(3):183-7. PubMed ID: 1791312
[TBL] [Abstract][Full Text] [Related]
20. [Cancer following treatment of Hodgkin disease].
Lustman F; Nouwynck C
Rev Med Brux; 1995; 16(3):138-40. PubMed ID: 7624666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
